These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21258112)

  • 41. Influenza and pneumococcal immunizations 2003-2004.
    Morgan R; Bresnitz EA; Tan C; Robertson C
    N J Med; 2003 Oct; 100(10):21-5. PubMed ID: 14606419
    [No Abstract]   [Full Text] [Related]  

  • 42. [Pneumococcal vaccine and influenza vaccine for prevention of exacerbation in patients with COPD].
    Matsuse H
    Nihon Rinsho; 2016 May; 74(5):839-42. PubMed ID: 27254956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessing predictors of influenza and pneumonia vaccination in rural senior adults.
    Madhavan SS; Borker RD; Fernandes AW; Amonkar MM; Rosenbluth SA
    J Health Soc Policy; 2004; 18(4):13-38. PubMed ID: 15447879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influenza vaccines to control influenza-associated bacterial infection: where do we stand?
    Christopoulou I; Roose K; Ibañez LI; Saelens X
    Expert Rev Vaccines; 2015 Jan; 14(1):55-67. PubMed ID: 25209381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double jeopardy: pneumococcal pneumonia following seasonal influenza.
    Schweon SJ
    Nursing; 2010 Dec; 40(12):60-1. PubMed ID: 21079486
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines.
    Nguyen-Van-Tam JS; Neal KR
    Semin Respir Infect; 1999 Jun; 14(2):184-95. PubMed ID: 10391412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age.
    Puig-Barberà J; Diez-Domingo J; Pérez Hoyos S; Belenguer Varea A; González Vidal D
    Vaccine; 2004 Dec; 23(3):283-9. PubMed ID: 15530669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 50,000 killed; cost $1 billion.
    Sobel E
    Del Med J; 1996 Nov; 68(11):557-9. PubMed ID: 8961622
    [No Abstract]   [Full Text] [Related]  

  • 49. [Vaccination against community acquired pneumonia in adult patients. A position paper by Neumoexpertos en Prevención].
    Redondo E; Rivero I; Vargas DA; Mascarós E; Díaz-Maroto JL; Linares M; Valdepérez J; Gil A; Molina J; Jimeno I; Ocaña D; Martinón-Torres F;
    Semergen; 2016 Oct; 42(7):464-475. PubMed ID: 27641310
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influenza and pneumococcal vaccination in older veterans: results from the behavioral risk factor surveillance system.
    Chi RC; Reiber GE; Neuzil KM
    J Am Geriatr Soc; 2006 Feb; 54(2):217-23. PubMed ID: 16460371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccination response following aerobic exercise: can a brisk walk enhance antibody response to pneumococcal and influenza vaccinations?
    Long JE; Ring C; Drayson M; Bosch J; Campbell JP; Bhabra J; Browne D; Dawson J; Harding S; Lau J; Burns VE
    Brain Behav Immun; 2012 May; 26(4):680-7. PubMed ID: 22386744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune response to influenza and pneumococcal vaccines in mice.
    Bessler H; Blay A; Djaldetti M
    Acta Virol; 2008; 52(2):125-9. PubMed ID: 18564900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of influenza vaccination and pneumococcal vaccination in elderly and high-risk patients seen in a university general medicine clinic.
    Lai H; Aronow WS; Gutwein AH
    Am J Ther; 2008; 15(6):528-30. PubMed ID: 19127136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. H1N1 vaccine, treatment updates for HIV/AIDS pts. Needle shot, pneumo vaccination, treatment options.
    AIDS Alert; 2009 Dec; 24(12):140-1. PubMed ID: 20063477
    [No Abstract]   [Full Text] [Related]  

  • 55. Risk modelling the mortality impact of antimicrobial resistance in secondary pneumococcal pneumonia infections during the 2009 influenza pandemic.
    Barnes CE; MacIntyre CR
    Int J Infect Dis; 2019 Aug; 85():1-6. PubMed ID: 31096052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Residents' role in immunizing adults: rationale, opportunity, obstacles, and strategies.
    Jacobson JA
    Virtual Mentor; 2012 Jan; 14(1):23-9. PubMed ID: 23116912
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy.
    Yee SS; Dutta PR; Solin LJ; Vapiwala N; Kao GD
    J Support Oncol; 2010; 8(1):28-34. PubMed ID: 20235421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccinating the elderly: recommendations and rationale.
    Berk SL; Alvarez S
    Geriatrics; 1986 Jan; 41(1):79-83, 87, 91. PubMed ID: 3940935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influenza and pneumococcal disease: does vaccination make a difference?
    Clover RD
    Ethn Dis; 2002; 12(1):S2-36-8. PubMed ID: 11913637
    [No Abstract]   [Full Text] [Related]  

  • 60. Point of care experience with pneumococcal and influenza vaccine documentation among persons aged ≥65 years: high refusal rates and missing information.
    Brownfield E; Marsden JE; Iverson PJ; Zhao Y; Mauldin PD; Moran WP
    Am J Infect Control; 2012 Sep; 40(7):672-4. PubMed ID: 22418612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.